{"": [95, 104, 0, 105, 1997, 0], "INTRODUCTION": [1998, 7841, 0], "Needle-free T4-CoV-2 nanovaccine stimulates robust humoral and cellular immune responses against SARS-CoV-2 and VOCs.": [7851, 15275, 0], "Needle-free T4-CoV-2 vaccination elicits robust mucosal immune responses.": [15276, 16863, 0], "Needle-free T4-CoV-2 vaccine provides complete protection and apparent sterilizing immunity against SARS-CoV-2 challenge.": [16864, 21363, 0], "A Beta-variant needle-free T4-CoV-2 vaccine stimulates strong mucosal, humoral, and cellular immune responses in hACE2-transgenic mice.": [21364, 26073, 0], "Needle-free T4-CoV-2-Beta vaccine provides complete protection and apparent sterilizing immunity against lethal infection by both the original SARS-CoV-2 and the Delta VOC in hACE2-transgenic mice.": [26074, 29625, 0], "The T4-CoV-2 vaccine is stable at ambient temperature.": [29626, 31126, 0], "T4-CoV-2 vaccination does not influence the microbiome community.": [31127, 34010, 0], "RESULTS": [7842, 34010, 1], "DISCUSSION": [34011, 45284, 0], "T4 bacteriophages and SARS-CoV-2 recombinant strains.": [45308, 46688, 0], "T4 bacteriophage production, purification, display, and stability evaluation.": [46689, 49543, 0], "Beta-S-trimer (tag-free) purification.": [49544, 52044, 0], "Mouse immunizations.": [52045, 53511, 0], "Bronchoalveolar lavage fluid collection.": [53512, 54182, 0], "ELISA determination of IgG, IgG subtypes, and IgA antibodies.": [54183, 55891, 0], "Virus neutralization assay.": [55892, 56994, 0], "T cell proliferation, phenotypes, and cytokine analysis.": [56995, 59413, 0], "16S rRNA gene sequencing and microbiome analysis.": [59414, 60430, 0], "Animal challenges.": [60431, 60987, 0], "Histopathology studies.": [60988, 63275, 0], "Viral load determination.": [63276, 63781, 0], "Photo credit.": [63782, 63920, 0], "Statistics and software.": [63921, 64413, 0], "Data availability.": [64414, 64505, 0], "MATERIALS AND METHODS": [45285, 64505, 1]}